MeSH Browser

MeSH Heading: Adrenergic beta-Antagonists
Tree Number(s): D27.505.519.625.050.200.200; D27.505.696.577.050.200.200
Unique ID: D000319
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000319
Annotation: general or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-AGONISTS
Scope Note: Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
Entry Version: ADREN BETA ANTAG
Entry Term(s): Adrenergic beta-Antagonist; Adrenergic beta-Receptor Blockader; Adrenergic beta-Receptor Blockaders; beta-Adrenergic Antagonist; beta-Adrenergic Antagonists; beta-Adrenergic Blocker; beta-Adrenergic Blockers; beta-Adrenergic Blocking Agent; beta-Adrenergic Blocking Agents; beta-Adrenergic Receptor Blockader; beta-Adrenergic Receptor Blockaders; beta-Adrenoceptor Antagonist; beta-Adrenoceptor Antagonists; beta-Blockers, Adrenergic
Previous Indexing: Sympatholytics (1966-1968)
Public MeSH Note: 95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94
Online Note: use ADRENERGIC BETA-ANTAGONISTS to search ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94 (as Prov 1969-72)
History Note: 95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)
Date Established: 1973/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Chemical Actions and Uses [D27]
- Pharmacologic Actions [D27.505]
  - Molecular Mechanisms of Pharmacological Action [D27.505.519]
    - Neurotransmitter Agents [D27.505.519.625]
      - Adrenergic Agents [D27.505.519.625.050]
        
        Adrenergic Antagonists [D27.505.519.625.050.200]
        
        Adrenergic alpha-Antagonists [D27.505.519.625.050.200.100]
        
        Adrenergic beta-Antagonists [D27.505.519.625.050.200.200]
        
        Adrenergic beta-1 Receptor Antagonists [D27.505.519.625.050.200.200.100]
        
        Adrenergic beta-2 Receptor Antagonists [D27.505.519.625.050.200.200.200]
        
        Adrenergic beta-3 Receptor Antagonists [D27.505.519.625.050.200.200.300]

Chemical Actions and Uses [D27]
- Pharmacologic Actions [D27.505]
  - Physiological Effects of Drugs [D27.505.696]
    - Neurotransmitter Agents [D27.505.696.577]
      - Adrenergic Agents [D27.505.696.577.050]
        
        Adrenergic Antagonists [D27.505.696.577.050.200]
        
        Adrenergic alpha-Antagonists [D27.505.696.577.050.200.100]
        
        Adrenergic beta-Antagonists [D27.505.696.577.050.200.200]
        
        Adrenergic beta-1 Receptor Antagonists [D27.505.696.577.050.200.200.100]
        
        Adrenergic beta-2 Receptor Antagonists [D27.505.696.577.050.200.200.200]
        
        Adrenergic beta-3 Receptor Antagonists [D27.505.696.577.050.200.200.300]

Adrenergic beta-Antagonists Preferred

Concept UI: M0000495
Scope Note: Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
Terms: Adrenergic beta-Antagonists Preferred Term
Term UI T001051
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1969); Adrenergic beta-Antagonist
Term UI T000998557
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021); Adrenergic beta-Receptor Blockader
Term UI T000998558
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021); beta-Adrenergic Antagonist
Term UI T000998559
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021); beta-Adrenergic Antagonists
Term UI T000941482
Date03/23/2018
LexicalTag NON
ThesaurusID NLM (2019); beta-Adrenoceptor Antagonists
Term UI T000941460
Date03/23/2018
LexicalTag NON
ThesaurusID NLM (2019); Adrenergic beta-Receptor Blockaders
Term UI T001046
Date02/02/1994
LexicalTag NON
ThesaurusID NLM (1995); beta-Adrenergic Receptor Blockaders
Term UI T001047
Date03/29/1974
LexicalTag NON
ThesaurusID UNK (19XX); beta-Adrenergic Blocking Agents
Term UI T001048
Date04/17/1989
LexicalTag NON
ThesaurusID IOM (1990); beta-Adrenergic Blockers
Term UI T001049
Date03/14/1994
LexicalTag NON
ThesaurusID NLM (1995); beta-Blockers, Adrenergic
Term UI T001050
Date04/17/1989
LexicalTag NON
ThesaurusID IOM (1990); beta-Adrenergic Blocking Agent
Term UI T000998561
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021); beta-Adrenergic Receptor Blockader
Term UI T000998562
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021); beta-Adrenoceptor Antagonist
Term UI T000998563
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021); beta-Adrenergic Blocker
Term UI T000998560
Date11/21/2019
LexicalTag NON
ThesaurusID NLM (2021)

Adrenergic beta-Antagonists MeSH Descriptor Data 2025